Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release Breastfeeding

Breast milk is superior in nutrition, It provides resistance against infections and allergies, It is naturally sterile. Despite all the advantages of breastfeeding some mothers choose to pause the breastfeeding in fear of harmful effects of medicines passing in breast milk. Are you wondering about breastfeeding and using Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release ? Know what is Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release and how it can affect your breast milk and whether Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release is safe for your kid or not.

What is Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release ?


Extended-release levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in patients 12 years of age and older with epilepsy. Extended-release levetiracetam tablet is indicated for adjunctive therapy in the treatment of partial onset seizures in patients 12 years of age and older with epilepsy (1)

Can I use Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release while breastfeeding?

Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release safe for breastfeeding
Active ingredient in Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release is Levetiracetam and based on our analysis of Levetiracetam it appears that using Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release is safe in breastfeeding. Below is analysis of Levetiracetam while breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Levetiracetam is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from extended-release levetiracetam tablets, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release Breastfeeding Analsys


Levetiracetam while Breastfeeding

Safe

CAS Number: 102767-28-2

Piracetam analog with nootropic and anti-epileptic effect. Authorized for use in children in Europe. Excreted into breast milk but infant serum levels were shown to be low. No other side effect than one case of hypotonia in a 7 days old premature whose mother was also on anti-epileptic medication. Seizures along with neonatal abstinence syndrome in a botlle fed neonate whose mother had taken Levetiracetam and Phenobarbital in pregnancy ocurred. Symptoms disappeared after initiation of breastfeeding.

Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release Breastfeeding Analsys - 2


Levetiracetam while Breastfeeding

CAS Number: 102767-28-2

Maternal doses of levetiracetam up to 3500 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. If levetiracetam is required by the mother, it is not a reason to discontinue breastfeeding. However, the infant should be monitored for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsants. Maternal serum level monitoring and dosage adjustment is advisable in the early postpartum period if the drug was taken throughout pregnancy and breastfeeding.[1] Some evidence suggests that levetiracetam might reduce the maternal breastmilk supply in some women.

Is Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release safe while breastfeeding

What if I already have used Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release?

Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.


My doctor has prescribed me Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release, what should I do?

Definitely, Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release, will my baby need extra monitoring?

No extra baby monitoring required while mother is using Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release


Who can I talk to if I have questions about usage of Levetiracetam Extended-release | Levetiracetam Tablet, Film Coated, Extended Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Keppra | Levetiracetam Injection, Solution, Concentrate
Spritam | Levetiracetam Tablet, For Suspension
Levetiracetam Injection Injection, Solution, Concentrate
Roweepra Xr | Levetiracetam Tablet, Extended Release